Cart
sales@molnova.com
Teneliximab
CAS No. 299423-37-3
Teneliximab( —— )
Catalog No. M36736 CAS No. 299423-37-3
Teneliximab (BMS 224819) is a chimeric monoclonal antibody and a tumor necrosis factor receptor superfamily member 5 (CD40) inhibitor that blocks CD40-CD40L interactions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 248 | Get Quote |
|
| 5MG | 407 | Get Quote |
|
| 10MG | 629 | Get Quote |
|
| 25MG | 908 | Get Quote |
|
| 50MG | 1260 | Get Quote |
|
| 100MG | 1665 | Get Quote |
|
| 200MG | 2241 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTeneliximab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTeneliximab (BMS 224819) is a chimeric monoclonal antibody and a tumor necrosis factor receptor superfamily member 5 (CD40) inhibitor that blocks CD40-CD40L interactions.
-
DescriptionTeneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number299423-37-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Maria A Argiriadi, et al. CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches. BMC Mol Cell Biol. 2019 Aug 5;20(1):29.?
molnova catalog
related products
-
α-Humulene
α-Humulene is extracted from S.officinalis essential oil.α-Humulene can inhibit tumor cell growth.α-Humulene also shows anti-inflammatory effects, probably by interfering with TNFalpha production and COX-2 and iNOS expression.
-
GSK963 (Racemate)
GSK963 (Racemate) a structurally distinct potent and selective inhibitor of RIP1 kinase(IC50=29?nM).
-
Thalidomide
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
